{
    "clinical_study": {
        "@rank": "57146", 
        "arm_group": [
            {
                "arm_group_label": "Simvastatin", 
                "arm_group_type": "Experimental", 
                "description": "Patients with COPD will receive simvastatin 40 mg once a day for 12 weeks"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Patients with COPD will receive placebo once a day during 12 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate in patients with stable Chronic Obstructive Pulmonary Disease (COPD) the\n      efficacy of statins (simvastatin) on: (1) endothelial function; (2) systemic inflammation;\n      (3)BODE (B: body mass , O: bronchial obstruction, D: dyspnea and, E: exercise tolerance)\n      index; (4) Uric acid; and, (5)vascular growth factors. Design: a 12 weeks randomized (1:1),\n      double-blind, placebo control study. Population: 18 males with stable COPD between 40-80\n      years of age, exsmokers, with Forced expiratory volume in one second (FEV1) between 30 and\n      80% predicted post-bronchodilation."
        }, 
        "brief_title": "Efficacy of Simvastatin for the Treatment of COPD", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Chronic Obstructive Pulmonary Disease", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Stable COPD between 40-80 years of age, exsmokers, with FEV1 lower that 80% predicted\n             post-bronchodilation.\n\n        Exclusion Criteria:\n\n          -  Severe co-morbidity (advanced-stage cancer, tuberculosis affecting more than a third\n             of the total lung parenchyma, pneumonectomy, pneumoconiosis, left cardiac  failure\n             previously reported, known cardiopathy with ventricular dysfunction (ejection\n             fraction < 45%) or any cardiovascular disease, Diabetes Mellitus treated with\n             insulin, Hypercholesterolemia, Chronic inflammatory diseases (asthma, rheumatoid\n             arthritis, lung fibrosis, autoimmune diseases), Treatment with systemic steroid, non\n             steroidal anti-inflammatory drugs or stains within 3 months prior to inclusion."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "18", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02070133", 
            "org_study_id": "EC08/00123"
        }, 
        "intervention": [
            {
                "arm_group_label": "Simvastatin", 
                "description": "Simvastatin 40 mg once a day during 12 weeks", 
                "intervention_name": "Simvastatin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo once a day during 12 weeks", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Simvastatin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Chronic Bronchitis", 
            "Statins", 
            "Endothelial dysfunction", 
            "Systemic inflammation", 
            "BODE index", 
            "Uric acid", 
            "Vascular growth factors"
        ], 
        "lastchanged_date": "February 21, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bunyola", 
                        "country": "Spain", 
                        "state": "Illes Balears", 
                        "zip": "07110"
                    }, 
                    "name": "Fundacio Caubet-CIMERA"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palma Mallorca", 
                        "country": "Spain", 
                        "state": "Illes Balears", 
                        "zip": "07010"
                    }, 
                    "name": "Hospital Son Espases"
                }
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pilot Study on the Efficacy of Statins for the Treatment of Chronic Obstructive Pulmonary Disease", 
        "overall_official": {
            "affiliation": "Hospital Son Espases, Palma Mallorca", 
            "last_name": "Ernest Sala, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Spain: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Endothelial Dysfunction (Arterial Stiffness)", 
            "safety_issue": "No", 
            "time_frame": "Day 1 and day 84 (end of of week 12)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02070133"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital Son Espases", 
            "investigator_full_name": "Ernest Sala", 
            "investigator_title": "Medical Doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Systemic inflammation", 
                "safety_issue": "No", 
                "time_frame": "Day 1 and day 84 (end of of week 12)"
            }, 
            {
                "measure": "BODE index", 
                "safety_issue": "No", 
                "time_frame": "Day 1 and day 84 (end of of week 12)"
            }, 
            {
                "measure": "Uric acid", 
                "safety_issue": "No", 
                "time_frame": "Day 1 and day 84 (end of of week 12)"
            }, 
            {
                "measure": "Vascular growth factors", 
                "safety_issue": "No", 
                "time_frame": "Day 1 and day 84 (end of of week 12)"
            }
        ], 
        "source": "Hospital Universitari Son Dureta", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Fundaci\u00f3 d'investigaci\u00f3 Sanit\u00e0ria de les Illes Balears", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Cimera", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Hospital Universitari Son Dureta", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}